Summary
Pharmacy spending rose 6% in Q4, with GLP-1 weight-loss drugs a major driver. Rebates came in higher than projected, and members asked whether federal drug-price efforts could bring costs down.
At a glance
- Total mentions
- 1
- Last 30 days
- 0
Last discussed Feb 27, 2026.
Impact analysis
Rebates and clinical savings overperformance total several million dollars, offsetting pharmacy cost growth.
Plan members benefit from rebate revenue offsetting drug costs.
Mentions & discussions (1)
We'll email you when it's on an upcoming agenda and when it's voted on, at most once a day.
The weekly brief for Tulare County
What the council decided, in plain English — one email a week.
Free. Unsubscribe with one click any time. We never sell your email.